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ABSTRACT: The impact of bcl-2 over-expression on the
glycosylation pattern of an antibody produced by a bcl-2
transfected hybridoma cell line (TB/C3.bcl-2) was investi-
gated in suspension batch, continuous and high cell density
culture (Flat hollow fibre, Tecnomouse system). In all
culture modes bcl-2 over-expression resulted in higher cell
viability. Analysis of the glycans from the IgG of batch
cultures showed that >95% of the structures were neutral
core fucosylated asialo biantennary oligosaccharides with
variable terminal galactosylation (G0f, G1f and G2f) con-
sistent with previous analysis of glycans from the conserved
site at Asn-297 of the IgG protein. The galactosylation index
(GI) was determined as an indicator of the glycan profile
(¼(G2þ 0.5 G1)/(G0þG1þG2)). GI values in control
cultures were comparable to bcl-2 cultures during exponen-
tial growth (0.53) but declined toward the end of the culture
when there was a loss in cell viability. Low dilution rates in
chemostat culture were associated with reduced galactosyla-
tion of the IgG glycans in both cell lines. However, at the
higher dilution rates the GI for IgG was consistently higher
in the TB/C3.bcl-2 cultures. In the hollow fibre bioreactor
the galactosylation of the IgG glycans was considerably lower
than in suspension batch or continuous cultures with GI
values averaging 0.38. Similar low galactosylation values
have been found previously for high density cell cultures
and these are consistent with the low values obtained when
the dissolved oxygen level is maintained at a low value (10%)
in controlled suspension cultures of hybridomas.
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Introduction
The maximisation of productivity in mammalian cell
cultures has been a vital goal for economically viable
manufacture of biotherapeutics (Butler, 2005; Warnock and
Al-Rubeai, 2006; Wurm, 2004). An important aspect of this
is the ability to maintain cells at a high concentration and
viability for an extended period of time in culture. However,
there are a variety of environmental signals including the
depletion of nutrients or the accumulation of metabolic by-
products that accompanies the stationary phase of culture
that often leads to apoptosis and a rapid decline in cell
viability.
Apoptosis has been found to be a major mechanism of cell
death in bioreactors of hybridoma (Al-Rubeai et al., 1990;
Simpson et al., 1997; Singh et al., 1994) as well as in CHO cell
lines (Goswami et al., 1999; Tey et al., 2000a). In contrast to
necrosis, apoptotic death is a regulated and controlled
process determined in a pre-programmed manner and plays
a vital role in tissue regulation. Apoptosis in cultured cells is
characterised by condensation, margination and fragmenta-
tion of chromatin, reduction in cellular volume and radical
changes in the cellular morphology which includes the
modification of cytoskeleton (Al-Rubeai, 1998). The cells
eventually fragment into apoptotic bodies that contain
cytoplasmic organelles and, usually, nuclear fragments.
Morphologically, necrosis, apoptosis, secondary necrosis
and viable cells can be easily identified using dual staining
of unfixed cells with acridine orange and propidium
iodide (PI).
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Apoptosis has been shown to result in a decrease in cell
viability during the death phase of mammalian cell cultures
(Singh et al., 1994, Mercille and Massie, 1994a,b) and
subsequently results in accumulation of proteases and cell
debris which may effect product integrity and complicate
down stream processing. Rapid progress has been made in
the identification of the factors that trigger apoptosis in
bioreactors and the development of strategies, which
prevent this form of death (Singh et al., 1996). The main
inducers of apoptosis in culture have been found to be
glutamine limitation, glucose limitation, and ammonia
toxicity (Mercille and Massie, 1994a; Simpson et al., 1997;
Singh et al., 1994), oxygen limitation (Mercille and Massie,
1994b; Simpson et al., 1997), excess oxygen (Simpson et al.,
1997), shear stress, sub-optimal pH and hyperosmolarity
(Perani et al., 1998) and amino acid deprivation (Simpson
et al., 1998; Singh et al., 1996).
Transfection with the anti-apoptosis gene, bcl-2 has proved
to be an effective strategy for the suppression of apoptosis in
the bioreactor environment (Simpson et al., 1997, 1999;
Al-Rubeai and Singh, 1998; Arden and Betenbaugh, 2004).
The transfected cell lines have been successfully adapted to
suspension culture and serum free media without prior
lengthy adaptation. Mammalian cells transfected with the bcl-
2 gene have been shown to exhibit improved robustness in
various environmental culture conditions known to induce
apoptosis (Bierau et al., 1998; Fassnacht et al., 1998, 1999;
Perani et al., 1998; Simpson et al., 1998, 1999). Moreover, the
suppression of apoptosis was also found to improve culture
productivity (Fassnacht et al., 1998; Simpson et al., 1997). In
addition, the prevention of cell death minimised the release of
DNA and proteases into the culture medium, which would be
expected to increase product stability and aid recovery in unit
operations.
The inhibition of apoptosis by bcl-2 has been shown to
affect protein glycosylation in some studies. Olsen et al.
(1996) showed that influenza virus-induced apoptosis could
be blocked by the presence of bcl-2 in MDCK cells in culture.
Viral replication was less efficient in the MDCK/bcl-2 cells
and this was partially attributed to a decreased level of
glycosylation in the viral hemagglutinin. Marquina et al.
(2004) studied the over-expression of bcl-2 in transgenic
mice. They showed that the autoimmune syndrome
developed in the mice was characterised by the production
of IgA with reduced sialylation and galactosylation. Many
studies have shown the positive impact of bcl-2 on cell
culture performance for the production of recombinant
proteins (Al-Rubeai, 1998; Arden and Betenbaugh, 2004).
However, there has been little reported on the impact of the
suppression of apoptosis on the post-translational mod-
ification of recombinant glycoproteins. The integrity and
consistency of these proteins are of vital concern to the
regulatory authorities, especially when the products are
intended for human therapeutic applications. Thus, the
main objective of this study was to investigate the impact of
bcl-2-induced suppression of apoptosis on the consistency
of the protein glycosylation.
Glycosylation is one of the most important post-
translational modifications that are known to affect the
structure and biological properties of glycoproteins (Jefferis,
2005). Immunoglobulin (IgG) contains 2–3% carbohydrate
by mass depending upon the species. IgG contains 2.3 N-
linked oligosaccharide chains per molecule in mice
(Mizuochi et al., 1987) and 2.8 in humans (Parekh et al.,
1985). Two of these represent the conserved glycosylation
sites in the Fc portion of all IgGs at Asn-297. The remainder
may be found in the hypervariable regions of the Fab of
some IgGs. The Fab glycans which are present in only a small
proportion of all IgG antibodies are characterised by a high
incidence of sialylated structures. The conserved Fc glycan at
Asn-297 is a biantennary structure with variable galacto-
sylation but limited sialylation. The position of the Fc
glycans between the CH2 domains of the heavy chains may
limit the accessibility of processing enzymes and this is the
likely cause of limited galactosylation. The terminal groups
of these Fc glycans vary between digalacto- (G2), mono-
galacto- (G1) and agalacto- (G0) structures and the
distribution of these glycoforms can be characteristic of
disease states. The normal human IgG content of galactose is
1.15 mol gal/glycan (GI¼ 0.57). Low galactosylation of IgG
may have a critical role in the pathology of autoimmune
disorders such as rheumatoid arthritis, lupus and erythe-
matosus (Kuroda et al., 2001; Kuroki et al., 2002) and can
occur through aging (Shikata et al., 1998). Functional
differences have been recognised between these glycoforms.
Agalactosylated IgG fails to activate complement (Nose and
Wigzell, 1983), is more liable to proteolytic attack
(Leatherbarrow and Dwek, 1983) and is not recognised
by cells expressing FcgRI and FcgRII receptors (Walker
et al., 1989).
It is well known that the pattern of glycoforms that arise in
recombinant proteins including monoclonal antibodies can
be affected by the cell line and culture conditions during
production (Andersen and Goochee, 1994; Jefferis et al.,
1990; Jenkins and Curling, 1994; Restelli and Butler, 2002).
Nahgrang et al. (1999) found that the glycosylation pattern
of recombinant human anti-rhesus D IgG1 varied sig-
nificantly when produced in SP2/0, CHO and BEK-293 cell
lines. Sheeley et al. (1997) compared the glycosylation of a
recombinant humanised murine monoclonal immunoglo-
bulin (CAMPATH) expressed in two different cell lines: a
murine myeloma (NS0) and CHO cells. The glycosylation
expressed in CHO cells was consistent with the one found in
native IgG while the antibody expressed in NS0 cells
included potentially hypergalactosylated immunogenic
oligosaccharide structures. These molecules contain the
Gal a(1–3) Gal terminal residues which are immunogenic in
humans. Hayter et al. (1992) found that glycosylation
patterns of interferon-g are dependent on the age of the cell
culture while monoclonal IgG produced in ascites, hollow
fibre bioreactors and static culture was shown to be
differently glycosylated (Cabrera et al., 2005; Lund et al.,
1993; Patel et al., 1992). Robinson et al. (1994) characterised
a recombinant IgG1 produced bymouse NS0 cell line during
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a serum-free, fed batch process. They observed that the
antigen-binding characteristics of the antibody remained
constant throughout the process but the carbohydrate
composition changed.
Because of these multiple factors that could affect protein
glycosylation in a condition where the rate of cell death is
altered it is now important to assess the impact of bcl-2 over-
expression on the glycosylation pattern of a secreted
glycoprotein. As a consequence the present study investi-
gated the effect of bcl-2-mediated suppression of apoptosis
upon the glycosylation of the secreted monoclonal antibody
(IgG1) in a murine hybridoma (TB/C3.bcl-2).
Materials and Methods
Cell Lines
The TB/C3 cell line is an NS1-derived murine hybridoma,
which produces immunoglobulin G subclass 1 (IgG1)
monoclonal antibody specific to the hapten Cg2 domain at
the Fc region of human IgG. The cell line was transfected
with bcl-2 carrier (TB/C3.bcl-2) or control plasmids (TB/
C3.pEF) as described in Simpson et al. (1997).
Medium
Cells were grown and maintained in RPMI 1640 supple-
mented with 5% ultra-low Ig foetal calf serum (Gibco-BRL,
Paisley, UK). The serum was treated with a proprietary
chromatographic procedure to remove gamma-globulin to a
concentration less than 5 mg/mL. This amounted to a
maximum concentration of 250 ng/mL in the complete
medium, which was unlikely to interfere with the analysis of
the hybridoma-secreted IgG.
Cell Maintenance
The cell lines were maintained in cultures in T-flasks or in
50–100 mL Duran bottles at 378C in RPMI 1640 medium
supplemented with 5% FCS. The cells were routinely sub-
cultured after 3 days from mid exponential growth phase.
Batch Cultures
Cells were resuspended in 250 mL medium to give an initial
viable cell density of 2 105 cells/mL in 500 mL Duran
bottles that were stirred magnetically at 75 rpm. Samples
were taken at 24 h intervals for routine cell counting and cell
fraction analysis. Supernatants (100 mL) were collected
during the growth phase (48 h post-inoculation) and during
the death phase (120 h post-inoculation) for glycosylation
analysis.
Continuous Cultures
Magnetically stirred culture flasks (Schott, Germany) were
modified to provide two inlets for medium and 5% CO2/air
and a single outlet for waste/exhaust gas. Medium was fed
continuously into the flasks using calibrated peristaltic
pumps. Outlets were arranged such that the culture working
volume remained at 250 mL for both cell lines. Two cultures
were run in parallel in a 378C water bath and fed from a
common 5 L reservoir of medium stored on ice. The
medium feeding rate was maintained over the passage of
approximately 10 culture volumes at each dilution rate.
Culture supernatants (typically 5 mL) were taken via the
reactor outlet on a daily basis when the vessel volume
reached its steady state at each dilution rate. The initial
dilution rate was 0.8 day1 and this was reduced step-wise to
0.2 day1. Culture samples were taken after at least two
volume changes of media following each change in dilution
rate. Steady state was assumed under each condition when
the cell concentration was constant over at least five daily
samples.
Tecnomouse High Density Culture System
A viable cell suspension (5 mL at 1 107 cells/mL in
complete medium) was loaded into an OxyCellR hollow
fibre cassette aseptically, one for each cell line. Temperature
was controlled at 378C and the cultures were aerated with
5% CO2/air. RPMI 1640 medium (without serum) was
circulated through the cassette at a flow rate of 100 mL/h
from a 2 L-reservoir bottle (kept on ice). Supernatants were
harvested from the extracapillary space at weekly intervals
and assayed for IgG. Glucose concentrations were deter-
mined using Reflolux IIR system (Boehringer Mannheim
GMBH, Munich, Germany). The circulating medium was
replaced at regular intervals so that the glucose concentra-
tion remained above 3 mM.
Cell Counting and Viability
Cells were counted in samples from suspension cultures by
the trypan blue exclusion method (Patterson, 1979).
Samples were mixed with an equal volume of 0.1% (w/v)
trypan blue solution and loaded into an improved Neubauer
haemocytometer counting chamber.
Apoptotic Cell Counting
Apoptotic scoring was carried out as described in Simpson
et al. (1997). Cells in suspension were mixed with an equal
volume of staining solution containing 10 mg/mL acridine Y
orange (AO) and 10 mg/mL PI. The number of viable (V),
apoptotic (A), secondary necrotic (SN) and necrotic (N)
cells was determined using rhodium coated improved
Neubauer haemocytometer under fluorescent microscopy
using blue light at 488 nm. The cells were classified by colour
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and chromatin morphology and expressed as a percentage of
the total cells (VþAþ SNþN).
Purification of IgG
IgG was purified from each supernatant sample by Protein
G-Sepharose 4 Fast Flow affinity chromatography as
described by themanufacturer’s manual (Pharmacia Biotech,
Uppsala, Sweden). Purified protein was detected in eluted
fractions by the Coomassie protein assay reagent (Pierce,
Rockford, IL).
Assay for Immunoglobulin G
Antibodies secreted by the TB/C3 cells were determined by a
standard sandwich-type enzyme-linked immunosorbent
assay (ELISA) as previously described (Al-Rubeai and
Emery, 1990). The plates (96-well) were coated with human
IgG as the capture antibody. IgG in culture supernatants were
detected by sheep anti-mouse IgG peroxidase conjugate, as
the secondary antibody and OPD (o-phenylenediamine
dihydrochloride) as substrate. The absorbance of each well
was then measured at 492 nm using a plate reader (SLT
Spectra, Salzburg, Austria). Sample IgG concentration was
obtained by comparing of the absorbance value against that
of the IgG standard curve.
Glycan Release From Immunoglobulin
The N-linked oligosaccharides were liberated from purified
IgG enzymatically using N-glycosidase F enzyme, PNGase F
as described in Routier et al. (1998). Two hundred
microlitres of release buffer (40 mM K2HP04, 10 mM Na-
EDTA pH 7.4), was added to 0.5 mg lyophilised glycoprotein
giving a concentration of 2.5 mg/mL sample. Samples were
dissolved using gentle vortex mixing. PNGase F enzyme
(1 unit, 5mL) was added to the sample and gently mixed. The
surface of sample-enzyme mixtures was then covered with
5 mL toluene and sealed with parafilm to avoid any
evaporation during incubation. Samples were incubated for
72 h in a water bath at 378C.
After the incubation period, the sample was placed on ice
to stop further enzymatic reaction. Cold absolute ethanol
(400 mL) was added to the sample and vortexed gently. The
mixture was allowed to precipitate on ice for 20 min.
The sample was centrifuged for 1 min at 6,500 rpm to
separate precipitated proteins from oligosaccharides. The
clear supernatant containing released oligosaccharides was
gently aspirated and transferred to a clean 1.5 mL Eppendorf
tube for glycan analysis. The precipitated protein was
washed in cold absolute ethanol (200 mL) four times to
ensure complete recovery of the glycans. The pool of
supernatants containing the glycans (approximately 1.2 mL)
was then lyophilised overnight prior to further analysis. The
precipitated deglycosylated protein was reconstituted in
250 mL PBS (approximately 2 mg/mL) and kept at 208C
prior to analysis by SDS–PAGE.
Glycan Desalting
Desalting was carried out using a 2 mL P-2 Bio-Gel (BioRad,
Hemel Hempstead, UK) size exclusion chromatography.
Lyophilised oligosaccharide samples were reconstituted with
60 mL degassed deionised double distilled water containing
0.02% sodium azide. The column flow rate was adjusted
using the clamp to get an effluent flow of 1 drop per 90 s
under gravity. The column was initially equilibrated with
three bed volumes of water. Once the sample solution was
absorbed into the column bed under gravity, the column
headspace was refilled with water and the eluent drops
collected (approximately 4 drops/tube; 6 min) for 26 tubes.
The tubes were then lyophilised overnight in a Savant S260
bench top vacuum drier. The pooled oligosaccharide
fractions were reconstituted with 60 mL deionised double
distilled water. The samples were then sterile filtered and
transferred into an ampoule and analysed.
HPEAC-PAD for Glycan Analysis
The oligosaccharide fractions liberated from glycoprotein
IgG were analysed by high pH anion exchange chromato-
graphy using pulsed amperometric detection (HPAEC-PAD;
Dionex Corp., Sunnyvale, CA). The Dionex DX500 system
was operated automatically by a pre-programmed operating
module adapted from Hardy and Townsend (1994). The
CarboPacTM PA-100 (4 250) and CarboPacTM PA-100
column guard were assembled to the system and the solution
flow rate was set up at 1 mL/min. The system was run at
308C. All the solutions were sparged with helium to displace
dissolved CO2. The oligosaccharide separation was per-
formed using a 0–250 mMNaOAc (gradient) in the presence
of 100 mM NaOH, over a period of 45 min. Between 12 and
23 mM NaOAc, neutral oligosaccharides were released while
between 23 and 250 mM NaOAc, sialylated oligosaccharide
structures were released. The separated oligosaccharides were
detected by PAD with a gold electrode and triple-pulse
amperometry (E1¼ 0.05 V, tl¼ 480 ms; E2¼ 0.75 V,
t2¼ 120 ms; E3¼ 0.2 V, t3¼ 60 ms).
Determination of the Neutral Glycans by RAD
The relative area distribution (RAD) of these three neutral
structures represented more than 95% of the total
oligosaccharides released while sialylated oligosaccharide
was only around 5% of the total structures released from
IgG. The neutral oligosaccharide peaks released from all the
samples analysed were identified using purified standard
oligosaccharides (Oxford Glycosciences, Oxford, UK),
which were separated under the same chromatographic
conditions.
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Galactosylation Index
The predominant glycan structures identified in the
immunoglobulin samples were agalactosylated, monogalac-
tosylated and digalactosylated. In order to compare the degree
of terminal galactosylation of the characterised structures, a
galactosylation index (GI) was assigned to each glycan profile,
determined from the relative areas of peaks as:
GI ¼ G2þ 0:5  G1
G0þ G1þ G2
where G0, G1 and G2 are the relative areas for the
agalactosylated, monogalactosylated and digalactosylated
glycans, respectively.
Monitoring bcl-2 Gene Over-Expression
The level of bcl-2 over-expression in the hybridoma, TB/
C3.bcl-2 was monitored at regular intervals by immunos-
taining of the bcl-2 protein usingWestern blotting (Simpson
et al., 1997).
Rates of Production
The specific rate of production of IgG in batch culture was
determined from the slope of a plot of the IgG concentration
against the integral values of cell concentration-time
(Renard et al., 1988).
Results
Growth and Production Characteristics in
Suspension Batch Cultures
The investigation was initiated by growing both the bcl-2
transfected (TB/C3.bcl-2) and control plasmid transfected
hybridomas (TB/C3.pEF) in suspension batch culture for
120 h. The viable cell density of both cultures is presented in
Figure 1. The viable cell density of the bcl-2 transfected culture
increased from its initial seeding concentration of around
2 105 cells/mL to approximately 1.0 106 cell/mL after 48 h
and to a maximum concentration of 1.1 106 cells/mL at
72 h. Themost significant difference between the two cultures
was in the rate of the decline phase. For the TB/C3.bcl-2 cells,
viable density declined gradually after 72 h and finally
dropped to around 7 105 cells/mL after 120 h post-
inoculation. For the control culture, the viable cell density
reached a maximum of around 11 105 cells/mL after 48 h
post-inoculation. The viable cell density then declined rapidly
during the next 48 h and finally reached zero at 120 h.
Cell Fraction Scoring
Fluorescence microscopic analysis of cells was performed by
double staining with a mixture of PI and acridine orange as
described in the Materials and Methods. The percentage of
viable, apoptotic, SN and necrotic cells in TB/C3.bcl-2 and
control, TB/C3.pEF cultures are presented in Figure 2a and
b, respectively. During the first 48 h of the Bc1-2 culture, all
the cells were viable. After 120 h post-inoculation, the viable
cell fraction decreased to 83%. The loss in viability coincided
with a slight increase in the necrotic cell fraction after 72 h
post-inoculation. The apoptotic and SN cell fraction
remained negligible for the duration of the culture. The
viability of the control cell line, TB/C3.pEF remained high
up to 48 h post-inoculation. However, a sharp decrease in
the viable cell fraction was observed after 48 h which
coincided with an increase in the fraction of apoptotic cells
and a sharp increase in the SN cell fraction (Fig. 2b). The SN
morphology is associated with late stage apoptosis as
previously described (Singh et al., 1994). The differences
between the two cell lines show the effect of bcl-2 in
maintaining a high cell viability over an extended period of
culture (TB/C3.bcl-2).
Immunoglobulin Production
The volumetric immunoglobulin (IgG1) production of both
TB/C3.bcl-2 and control, TB/C3.pEF cultures are also
presented in Figure 1. A similar amount of product was
released by both cell lines from the beginning of each culture
but the IgG concentration of the control culture was higher
Figure 1. Growth in suspension batch cultures of TB/C3.pEF (*) and TB/C3.bcl-
2 (*) cells. Cells were inoculated into 250 mL RPMI 1640 medium with 5% FCS to give
an initial viable cell density of 2 105 cells/mL. Cultures were held in 500 mL Duran
bottles that were stirred magnetically at 75 rpm. Viable cell concentrations were
determined by the trypan blue exclusion assay for TB/C3.pEF (*) and TB/C3.bcl-2 (*)
cells (continuous line). Daily samples were taken from TB/C3.pEF (~) and TB/C3.bcl-2
(~) cultures and the IgG concentration of supernatants were determined by ELISA
(broken line). Sample size, n¼ 8, error bars represent 95% confidence limits.
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between 48 and 96 h post-inoculation after which there
appeared to be no further Ig production. It is be noted that
the culture period between 48 to 96 h corresponded to the
rapid loss of viability of these cells and it is probable that a
significant amount of Ig was released during cell lysis that
occurred during the necrotic phase shown in Figure 2. For
the TB/C3.bcl-2 culture, after a 1 day lag there was a gradual
increase in Ig throughout the culture up to 120 h. This
corresponded to the high cell viability that was maintained
with only a slight decrease to 85% after 120 h. Although the
cultures were terminated at 120 h, it is likely that the IgG1
concentration would have continued to increase beyond the
maximum of 70 mg/L that was reached. The increased
volumetric productivity of the bcl-2 transfected batch
cultures during an extended death phase has previously
been reported (Simpson et al., 1997).
The specific productivity (QP) of each culture was
analysed from the integrated values (viability indices)
obtained from the growth curve and regression analysis.
This showed that in both cases the production of antibody
was independent of the phase of culture but was directly
related to the number of viable cells. Specific productivities
(QP) were obtained from the slopes of these plots. TheQP for
the TB/C3.pEF was 28.5 0.9 pg/cell per day whereas theQP
for the TB/C3.bcl-2 was significantly lower at 18.3 0.5 pg/
cell per day.
The Glycosylation Profiles of Monoclonal IgG1 in
Suspension Batch Cultures
The IgG isolated from culture samples was deglycosylated
enzymatically. The liberation of glycans from the IgG
samples was demonstrated by the mobility shift of bands for
deglycosylated compared to glycosylated samples as shown
by SDS–PAGE gels (data not shown). The positional shift of
the bands observed in the gels following deglycosylation
corresponded to a weight loss of around 2%, which is the
expected mass of glycans attached to IgG (Deisenhofer,
1981).
Glycosylation analysis was carried out on samples of the
monoclonal IgG1 produced at exponential (48 h) and
decline (120 h) culture phases of both bcl-2 transfected and
control hybridoma cell cultures by HPAEC-PAD. The
profiles of oligosaccharides liberated from IgG1 are
presented in Figure 3. In all four chromatograms presented,
there are three prominent neutral oligosaccharide peaks
clearly separated when the sodium acetate concentration
was gradually increased from 12 mM (at 5.1 min) to 23 mM
(at 21.9 min). With reference to the standard oligosacchar-
ides, these peaks were identified as G0f (asialo-agalacto-
complex type biantennary oligosaccharide with core
substituted with fucose), Glf (asialo-monogalacto-complex
type biantennary oligosaccharide with core substituted with
fucose) and G2f (asialo-digalacto-complex type biantennary
oligosaccharide with core substituted with fucose), respec-
tively. The RAD of these peaks was determined using the
PeakNetTM programme.
In bcl-2 transfected samples, at maximum growth (48 h),
the largest proportion of the glycans liberated were Glf
structures, representing 45% of the total RAD of all the three
oligosaccharides. The RAD of G0f and G2f structures were
around 24 and 31%, respectively. However, at 120 h, both
Glf and G2f structures (with RAD of around 44 and 40%,
respectively) were the larger proportions with the RAD of
G0f remaining the lowest, around 16% of the total RAD.
For the control samples at 48 h the largest proportion of
oligosaccharides liberated was also Glf structures, represent-
ing around 43% of the total RAD. The RAD of G0f and G2f
structures was around 26 and 31%, respectively. However, in
contrast to the bcl-2 transfected culture, for the late phase
samples (120 h), there was an increase in G0f with a decrease
in G2f. The other two structures, G0f and G2f were
Figure 2. Change in cell fractions in suspension batch cultures. The % of viable
(*), apoptotic (&), secondary necrotic (~) and necrotic (!) cells were determined
by fluorescence microscopy for (a) TB/C3.bcl-2 cells and (b) TB/C3.pEF cells. Sample
size n¼ 100, error bars represent 95% confidence limits.
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represented with RAD values of around 30 and 24%,
respectively. The largest proportion was represented by the
Glf structure with a RAD of around 46% of the total
oligosaccharide RAD. It is interesting to note that Glf
structure predominates in all the four samples. The small
peaks at a retention time >15 min may correspond to a
minimal proportion of sialylated glycan structures but these
were not analysed.
The GI for each sample is shown in Table I as a measure of
the extent of galactosylation from this analysis. The error
associated with these values is normally below 3% (Kunkel
et al., 1998). The samples from both cell lines taken at late-
exponential phase (48 h) show no significant difference
(0.53) whereas for the decline phase culture samples, the
galactosylation of the bcl-2 samples (0.62) is significantly
Figure 3. Typical glycan profiles of immunoglobulins extracted from suspension batch cultures. The chromatograms of oligosaccharides were obtained by HPAEC-PAD
analysis of IgG samples of (a) TB/C3.bcl-2 and (b) TB/C3.pEF cultures. Samples were taken during (i) exponential and (ii) decline phases in suspension batch culture. Peaks 1, 2 and 3
were identified as G0f, G1f and G2f respectively with reference to standard oligosaccharides.
Table I. Galactosylation indices of Ig glycans from suspension cultures.
Sample time TB/C3.pEF TB/C3.bcl-2
Exponential phase (48 h) 0.53 0.54
Decline phase (120 h) 0.47 0.62
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higher than control (0.47). This result shows that in the
decline phase (up to 120 h) the bcl-2 transfected culture with
a viability of around 85–90% produced a greater degree of
galactosylation of the IgG glycans. This suggests that bcl-2
over-expression prolonged cell viability leaving the cells
intact and able to continue a relatively high level of
galactosylation. The control cells had a significantly lower
viability at that stage and released IgG with lower
galactosylation. This difference in the observed level of
terminal glycan galactosylation of Ig between the two
cultures could be explained by loss of functional galacto-
sylation in the control cultures during the decline phase or
by an enhanced activity of glycosidases resulting from cell
lysis.
Cell Growth and Production Characteristics
in Continuous Cultures
Continuous chemostat cultures enabled the establishment of
steady state conditions at various dilution rates. This system
offers an excellent environment to investigate the impact of
bcl-2 over-expression on product glycosylation under
optimal conditions over extended periods of time and at
different dilution rates (Simpson et al., 1999).
The results of cell growth characteristics in relation to
dilution rates of bcl-2 transfected hybridoma and the
control cell line are shown in Figure 4. The experiment was
carried out in continuous mode from the highest dilution
rate of 0.8 day1 and gradually decreased to 0.2 day1.
For this range of steady states the specific growth rates
(m) corresponded to 0.0083–0.033 h1. These values can be
compared with the maximum specific growth rates (mmax)
observed in batch culture of 0.042 h1 (TB/C3.pEF) and
0.039 h1 (TB/C3.bcl-2).
At a dilution rate of 0.6 day1 and above, the viability of
both cell lines remained above 90%, with the viable cell
concentration at 1.4 106 cells/mL. At 0.5 day1 and below,
there was a significant difference in viability and viable cell
concentration between the two cell lines. For the TB/C3.bcl-
2 cells at dilution rates of 0.5–0.3 day1, viability remained
above 90% and the viable cell concentration remained above
1.4 106 cells/mL. In contrast there was a marked decrease
in viability and a slight decrease in viable cell concentration
from 0.5 to 0.3 day1 in the control cell line culture. A
marked decrease in viability and viable cell number was
clearly evident in the TB/C3.bcl-2 cells from dilution rates of
0.3 to 0.2 day1. However, in comparison, the decrease in
viability and viable cell concentration of the control cell line
from 0.3 to 0.2 day1 was much greater (below 40% and
6 105 cells/mL, respectively).
Using fluorescence microscopic analysis of nuclear
morphology a decrease was shown in viability of bcl-2
transfected cells that was coincidental with the increase in
apoptotic and necrotic cells while the decrease in viability of
control cell lines coincided with an increase in apoptotic
cells only as shown in Figure 4.
The Glycosylation of IgG Produced at Different Dilution
Rates in Continuous Culture
The glycosylation profiles of IgG from bcl-2 transfected and
control cells were determined at each dilution rate. The three
prominent peaks were separated in all the samples and were
identified as neutral oligosaccharides, namely G0f, Glf and
G2f with reference to standard oligosaccharide profiles. The
RAD of these peaks was determined at each dilution rate. At
Figure 4. Growth characteristics in continuous cultures. Steady state contin-
uous cultures (250 mL) were established for TB/C3.bcl-2 cells (panel a) and TB/C3.pEF
cells (panel b) in magnetically stirred flasks. Medium was continuously fed into the
flasks using calibrated peristaltic pumps from a common 5 L reservoir of medium
stored on ice. The volume of each culture remained constant at 250 mL. The viable cell
concentrations (*) were determined by the trypan blue exclusion assay from 5 mL
samples obtained at regular intervals. The % of viable (*), apoptotic (&), secondary
necrotic (~) and necrotic (!) in each of the cell populations was determined by
fluorescence microscopy. Sample size, n¼ 8, error bars represent 95% confidence
limits.
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a dilution rate of 0.4 day1 and above, samples analysed
were dominated by the Glf structure, representing more
then 50% of the total RAD while G0f and G2f remained
around 25% each peak. At dilution rates of 0.3 day1 and
below, the RAD of Glf in all the samples analysed was
reduced and the G0f was slightly increased. The RAD of G2f
remained below 25% of the total peak RAD.
Similar patterns of RAD were observed at all dilution rates
in the control cell line as were observed in the TB/C3.bcl-2
cultures. In these cultures, the glycan galactosylation of IgG
from both cell lines increased with dilution rates (0.4–0.8
day1) in comparison to lower dilution rates (0.2–0.3 day1).
A plot of the GI of glycans isolated from Ig from cultures
at varying dilution rates is shown in Figure 5. The range of
values extended from 0.36 to 0.59 with the minimum value
occurring at a dilution rate of 0.3 day1 and themaximum at
0.7 day1. It is noted that the GI value increases steadily for
both cell lines in cultures between these two dilution rates.
This suggests that the extent of galactosylation increases with
the specific growth rate of the cells. An alternative
explanation is that the galactose is removed by a higher
activity of extracellular glycosidases in the slower growing
cultures, where the residence time of secreted IgG is higher.
Overall there appears to be a consistently higher index of
galactosylation for Ig produced from the TB/C3.bcl-2 cells
compared to the control TB/C3.pEF cells (P¼ 0.01 by paired
t-test).
The Effect of bcl-2 Over-Expression on the IgG
Glycosylation Profiles From Cells in High Cell
Density Cultures
The influence of bcl-2 over-expression on antibody fidelity
in the Tecnomouse Hollow Fibre system (Integra Bios-
ciences, Chur, Switzerland) was carried out in this study.
This system is a continuous perfusion system where cells and
products are retained in a flat hollow fibre cassette with a
continuous supply of medium and a continuous out flow
of spent medium. Five millilitres of cell suspension (5
106 cells/mL) of each cell line (TB/C3.bcl-2 and TB/C3.pEF)
was inoculated into the extracapillary spacing of two
separate hollow fibre cassettes as described in Materials and
Methods. The cell growth was monitored by measurement
of glucose consumption. To ensure maximum nutrient
supply, 2 L of medium was circulated through the cassette at
100 mL/h. The glucose level was maintained above 2.5 mg/
mL throughout the duration of the culture. Five microlitres
of the supernatant from the extracapillary space (i.e. the
product harvest) was withdrawn weekly and replaced with
an equal volume of fresh medium. The dead cells from the
culture were counted by the trypan blue exclusion method
and remained below 104 cells/mL at every harvest for the
entire duration of the culture.
Productivity From High Density Cultures
Both cell lines were grown under optimal culture conditions
for 6 weeks. The supernatant from each culture was
harvested on a weekly basis and the IgG concentration
determined over the course of the culture. The IgG
concentrations from the TB/C3.bcl-2 and control TB/
C3.pEF cultures are presented in Figure 6. There was a
Figure 5. Galactosylation indices of glycans released from IgG samples
secreted by TB/C3.pEF (*) and TB/C3.bcl-2 (*) cells in cultures maintained at
various dilution rates. The culture conditions are described in the legend for
Figure 4.
Figure 6. The volumetric production of immunoglobulin (IgG) from TB/C3.pEF
and TB/C3.bcl-2 cells in high density cultures (Tecnomouse system). Samples har-
vested during weeks 1–6 were analysed for IgG by ELISA as reported in Fassnacht
et al. (1999).
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marked difference in the production of monoclonal IgG
from bcl-2 transfected to control culture through out the 6
weeks culture duration. The monoclonal mouse IgG
production increased from around 2 mg/mL in week 1 to
around 14 mg/mL in week 6. In the control culture, the
increase in IgG production was slower with a maximum
concentration of around 8 mg/mL in week 6. Clearly, bcl-2
over-expression had a substantial impact on the productiv-
ity of the cells in this high cell density production system.
Using the IgG purified from the supernatants of the
experiment described above, the impact of bcl-2 transfection
and the effect of culture duration in both cultures with
respect to product glycosylation profiles were then
investigated and the results are presented below.
The Glycosylation Profiles of IgG From High
Density Cultures
The IgG samples from both bcl-2 transfected and control
hybridoma cultures harvested in weeks 1, 3 and 6 were
chosen to study glycosylation profiles. The RAD of the three
prominent glycan peaks is presented in Figure 7. For the bcl-
2 cultures, the percentage of G0f was slightly decreased from
around 50% at week 1 to approximately 40% at week 6.
While the galactosylated structure, Glf was slightly increased
from approximately 35% at week 1 to approximately 45% at
week 6. The galactosylated. G2f structure increased slightly
from over time from 14 to 16%. In control cultures, the
percentage of G0f structure was slightly lower compared to
the bcl-2 cultures at 37% in week 1 and decreased slightly to
approximately 30% in week 6. The percentage of Glf
structure was slightly increased from 45% in week 1 to 55%
in week 6, while the G2f structure remained constant at 15%
between week 1 and week 6.
The GI was determined for each sample analysed
(Table II). The results show an increased galactosylation
for samples from the TB/C3.bcl-2 cultures from week 1 to
week 6, whereas for the control cultures there was only a
slight increase from week 1 to week 3. The GI values were
slightly but significantly lower for the IgG from the TB/
C3.bcl-2 cultures compared to the controls (P< 0.05).
However, it is to be noted that these GI values are all
significantly lower than those obtained from suspension
batch cultures.
Discussion
The impact of bcl-2 over-expression on growth and
productivity of industrially important mammalian cell lines
has attracted considerable attention since the mid 1990s.
There is a positive impact of this protein on cell robustness
and prolonged cell survival under environment stress in
culture (Goswami et al., 1999; Itoh et al., 1995; Simpson
et al., 1997; Singh et al., 1996; Tey et al., 2000a,b).
In this study, the impact of bcl-2 over-expression in a
murine hybridoma on immmuoglobulin glycosylation was
investigated. The growth profile of the bcl-2-transfected cell
line shows that compared to a control a high viability of
the cells was maintained for several days after attaining
the maximum cell density. It is well recognised that B-
lymphocyte hybridomas are particularly susceptible to
apoptosis, manifested by the absence of a stationary phase
and a rapid decline in cell viability following the peak of cell
Figure 7. The relative distribution of glycans of IgG extracted from high density
cultures. Values were determined from the relative peak area distributions obtained by
HPAEC-PAD analysis of glycans from (a) TB/C3.bcl-2 and (b) TB/C3.pEF cultures at
weeks 1, 3 and 6 as indicated.
Table II. Galactosylation indices (GI) for samples from the Tecnomouse.
Sample time TB/C3.pEF TB/C3.bcl-2
Week 1 0.398 0.326
Week 3 0.408 0.344
Week 6 0.408 0.388
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density. From analysis of the cell populations in our study it
is clear that bcl-2 retards this effect by reducing the rate of
apoptosis.
High protein production from a mammalian cell culture
depends upon two important factors; a high cell specific
productivity, as well as the attainment and maintenance of a
high cell density. For the TB/C3 cells analysed in this study,
the effect of bcl-2 was to reduce the cell specific productivity.
This resulted in lower concentrations of IgG during the
exponential growth phase. However, the extended viability
of the TB/C3.bcl-2 cells at peak cell density allowed IgG
production to be continued for longer and at a point where
production had stopped in the control cells. The net effect of
these opposing effects was that the volumetric production of
IgG was higher at the end of the TB/C3.bcl-2 cell culture.
Analysis of the glycan profiles of the IgG from these
cultures by HPAEC-PAD showed three major peaks that are
characteristic of the two conserved glycan structures at Asn-
297, located in the interstitial space between the two heavy
chains at the CH2 domain (G0f, G1f and G2f). Different
structural profiles are associated with changes in the relative
peak areas that result from variable terminal galactosylation
of the glycans. These three glycoforms amounted to 95% of
the structures identified by the HPAEC system. Smaller
peaks at higher retention times suggested the presence of a
minimal amount of sialylated structures as previously
identified with a similar separation (Kunkel et al., 1998). The
G1f peak is likely to contain two isomers with the possibility
of the single terminal galactose attached to either the a1–3
or the a1–6 antenna of the core mannose residue. Although
38 possible glycan structures have been identified from IgG
isolated from 12 different mammalian species, the propor-
tion found in mouse IgG is limited and predominantly
represented by the biantennary core fucosylated asialo
structures shown by HPAEC (Raju et al., 2000). Mouse IgG
glycans are almost wholly fucosylated and contain no
bisecting N-acetylglucosamine, that are present in human,
rabbit and bovine IgG (Mizuochi et al., 1987). Minor
incomplete structures have been identified, particularly
under conditions of cellular stress (Serrato et al., 2004).
However, the extent of terminal galactosylation of the
biantennary structures on either heavy chain of IgG has been
considered to be the main source of variability in mouse IgG
(Masuda et al., 2000).
This variability can be quantified by the GI, which has
theoretical limits of 0–1. Generally the variability is found in
differences between the relative contents of G0f and G2f with
the G1f remaining constant. An analysis of galactosylation of
immunoglobulin from normal serum showed GI values of
0.62 for bovine IgG and 0.57 for human IgG (Kunkel et al.,
1998). From this earlier work the effect of DO on the glycan
structures from a murine hybridoma in culture showed an
increase of GI from 0.32 to 0.56 as the DO level was
increased from 10 to 100%. These values are comparable
with the GI values obtained from glycan analysis of both TB/
C3 cell lines during the exponential phase when cultured
under identical conditions. However, there appeared to be a
significant difference in the values during the decline phase;
with a decrease in the value from TB/C3.pEF cultures and an
increase in the TB/C3.bcl-2 culture. We might speculate that
this difference could be related to the enhanced viability of
the cells in the TB/C3.bcl-2 culture and the possibility of the
release of glycosidases from the TB/C3.pEF cells.
The activities of fucosidases, b-galactosidases, b-hexosa-
minidase and sialidase have been shown to accumulate in
the extracellular medium of CHO cells (Warner, 1999). Such
glycosidases could also be secreted by hybridoma cells to
cause some loss of terminal galactose. Alternatively, the
efficiency of the galactosyl transferase enzyme necessary for
galactosylation could be reduced in TB/C3.pEF cells at the
point in the decline phase when the IgG samples were taken.
Reduced efficiency of glycosylation has been generally
observed for other cell lines toward the end of a culture
(Hooker et al., 1995). Limiting nutrients could result in a
reduced efficiency of glycosylation due to limited sources for
energy supply and nucleotide sugar synthesis. Nyberg et al.
(1999) observed reduced glycosylation site occupancy of
interferon-g (IFN-g) produced by CHO cell lines during a
period of glutamine and glucose starvation. Another
contributing factor could be the release of incompletely
glycosylated molecules from transport vesicles during the
transfer of these molecules between the Golgi apparatus
when the cells burst.
Continuous chemostat culture is a valuable experimental
tool for determining the effects of culture parameters during
steady state growth conditions of cells. Here we show the loss
of cell viability as dilution rates are reduced from 0.8 to
0.2 day1. This data was first reported by Simpson et al.
(1999) and shows that bcl-2 can protect the loss of viability.
Analysis of the cell populations within this dilution range
shows a significantly higher number of SN cells in the TB/
C3.pEF culture compared to the TB/C3.bcl-2. This is an
indication of late stage apoptosis.
At a dilution rate of 0.5 day1 and higher, the antibody
titre was similar in both cultures. Only at dilution rates of 0.3
and 0.4 day1 was there a significant difference between cell
lines with a significantly higher Mab titre in the TB/C3.pEF
cultures (54–64 mg/mL). This divergence at these dilution
rates could be explained by the fall in viability of the TB/
C3.pEF cells and the possibility of the rapid release of
antibody from SN cells. From the results presented in this
article, analysis of the galactosylation of the glycans
extracted from the IgG produced shows that the GI values
increase significantly at higher dilution rates with values
above 0.5 being characteristic of batch cultures and growth
in bioreactors at higher oxygen levels (Kunkel et al., 1998).
Similar changes in glycosylation profile at low dilution
rates were previously reported in continuous culture of
CHO producing IFN-g. Hayter et al. (1992) found that
despite the changes in IFN-g production rate and cell
physiology, the profile of IFN-g glycosylation was similar at
all dilution rates except at the lowest growth rates where
there was an increase in production of non-glycosylated
IFN-g. The increase in non-glycosylated IFN-g was thought
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to be due to glucose and glutamine limitation, which occur
at low dilution rates (Nyberg et al., 1999). Glutamine and
glucose are the major nutrients for cell growth and these are
likely to be limiting at the lower dilution rates. Glutamine
limitation appears to influence glycosylation by reducing
amino sugar formation and hence UDP-GNAc (UDP-
GIcNAc and UDP-GaINAc) concentration. (Nyberg et al.,
1999). Other nucleotide sugars such as UDP-glucose, GDP-
mannose and UDP-GlcNAc are derived from glucose-6-
phosphate and fructose-6-phosphate and are also influenced
by glucose limitation (Hayter et al., 1992).
Hayter et al. (1992) suggested an alteration of glycosyl
transferase enzyme activities due to the onset of cell death to
explain the reduced glycosylation at low dilution rates.
However, this is an unlikely explanation in our study
because low galactosylation of IgG was found in cultures of
both cell lines at low dilution rates even though the viability
of the TB/C3.bcl-2 was significantly higher than the control
cells. The reduced galactosylation at low dilution rates (0.2
and 0.3 day1) could be related to the increase in culture
residence time. This would cause the accumulation of
metabolic by-products to higher concentrations. Ammonia
in particular has been shown to have a significant effect on
glycan microheterogeneity (Yang and Butler, 2000).
Similarly any extracellularly released glycosidases could
increase to higher levels causing an increased likelihood of
glycan degradation.
At higher dilution rates (0.5–0.8 day1) and correspond-
ingly higher cell growth rates the TB/C3.bcl-2 cells appeared
to produce IgG with a slightly but significantly higher
galactosylation. This is difficult to explain because the
growth characteristics of the two cell lines appear to be the
same within this dilution range. However, at least it
shows that the use of bcl-2 to limit the rate of apoptosis
in these cells does not adversely affect the microheter-
ogeneity of glycosylation. These finding are important for
strategic modification of cell culture systems for product
optimisation.
The Tecnomouse culture system offers the possibility of
process intensification by a continuous perfusion high cell
density cultures over extended periods of time. This has the
advantage of continuous production of antibodies over
periods of several weeks. The design of the hollow fibre
cassettes enables continuous feeding of fresh medium to
the cells that are held in the extracapillary space from which
the high molecular weight products like antibodies can also
be harvested.
The hybridoma cell line was shown to grow successfully in
the Tecnomouse culture system (Fassnacht et al., 1999).
After the first week the IgG production from the TB/C3.bcl-
2 culture was significantly and consistently higher than the
TB/C3.pEF culture. After 6 weeks the IgG production from
the bcl-2 culture was twofold higher than the control culture.
If it is assumed that the specific productivity of the TB/
C3.bcl-2 cells was lower than the TB/C3.pEF cells as was
shown in suspension culture, then the higher Mab titre must
be related to a significantly higher cell density in the TB/
C3.bcl-2 culture. This might be explained by the enhanced
robustness of these cells and the ability to withstand adverse
conditions that could cause loss of viability in the control
cells.
Analysis of the glycans extracted from the IgG produced
in the Tecnomouse system at three separate time points
showed that the extent galactosylation as quantified by GI
(mean¼ 0.38) was significantly and consistently lower than
the values obtained in batch and continuous cultures. A
possible explanation for this is that the cells could be
exposed to adverse conditions that could arise through
generation of the very high cell densities. High cellular
demand could result in a nutrient and oxygen depletion as
well as an unfavourable pH. There is a likelihood that
gradients of nutrients, pH and oxygen developed within the
mass of cells as they reach the tissue-like cell densities within
the culture system.
A previous report has shown that a low DO can result in
reduced galactosylation of IgG glycans with GI values similar
to the ones reported here (Kunkel et al., 1998). Thus, we can
speculate that the low GI values in the Tecnomouse system
maybe a result of the oxygen gradients that undoubtedly
arise within the hollow fibres as the cells reach high densities.
The GI value for the TB/C3.bcl-2 culture was significantly
lower (mean¼ 0.35) than that from the TB/C3.pEF
culture (mean¼ 0.41). Although this appears to contradict
the results from the other culture systems, this difference
may be a reflection of the higher cell densities that would
have been achieved in the TB/C3.bcl-2 culture compared to
the control culture to maintain the high IgG production.
The higher cell densities could produce the low DO levels
known to adversely affect galactosylation.
Similar results were obtained by Cabrera et al. (2005) who
studied the galactosylation of a hybridoma producing IgG in
several different culture systems. They reported higher
galactosylation of IgG produced from static culture flasks
and spinner flasks with GI values consistently above 0.5 as
reported for our cell lines in batch and continuous cultures.
However, production of the same IgG in mouse ascites, a
hollow fibre bioreactor or a membrane bioreactor produced
significantly lower galactosylation. The GI level obtained
from their hollow fibre system was 0.28 which was even
lower than the value obtained in our Tecnomouse culture.
The findings of Cabrera et al. (2005) support our hypothesis
that the conditions prevailing in the high density cultures
may cause an adverse environment for galactosylation of the
immunoglobulins.
In conclusion, we found that the galactosylation of IgG
produced in suspension batch cultures was equivalent to
that found in polyclonal antibodies from animal sera or
from bioreactors maintained with a DO set-point at or
above 50% air saturation. Lower cellular growth rates in
continuous culture reduced the level of galactosylation
(GI< 0.5), although the IgG produced from bcl-2 trans-
fected cells had consistently higher GI values. This was partly
related to the enhanced cell viability in these cultures. The
high cell densities obtained in a hollow fibre culture system
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resulted in high IgG production over an extended time
period. However, this was associated with a significantly
lower galactosylation of IgG compared to that obtained in
stirred suspension cultures.
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